Global Inflammatory Bowel Disease Drugs Market Professional Survey Report 2016

This report
Mainly covers the following product types
The segment applications including
Segment regions including (the separated region report can also be offered)
USA
China
Europe
South America
Japan
Africa
The players list (Partly, Players you are interested in can also be added)
Merck & Company
Janssen Pharmaceuticals
Abbvie
Biogen Idec
UCB
Shire
Pfizer
Novartis
Novo Nordisk
Boehringer Ingelheim
Salix Pharmaceuticals
Genentech
Amgen
Mitsubishi Tanabe
Akebia Therapeutics
Celltrion
ChemoCentryx
Ferring Pharmaceuticals
With no less than 15 top producers.

Data including (both global and regions): Market Size (both volume - K Doses and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Dose, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Table of Contents

1 Industry Overview of Inflammatory Bowel Disease Drugs
1.1 Definition and Specifications of Inflammatory Bowel Disease Drugs
1.1.1 Definition of Inflammatory Bowel Disease Drugs
1.1.2 Specifications of Inflammatory Bowel Disease Drugs
1.2 Classification of Inflammatory Bowel Disease Drugs
1.3 Applications of Inflammatory Bowel Disease Drugs
1.4 Industry Chain Structure of Inflammatory Bowel Disease Drugs
1.5 Industry Overview and Major Regions Status of Inflammatory Bowel Disease Drugs
1.5.1 Industry Overview of Inflammatory Bowel Disease Drugs
1.5.2 Global Major Regions Status of Inflammatory Bowel Disease Drugs
1.6 Industry Policy Analysis of Inflammatory Bowel Disease Drugs
1.7 Industry News Analysis of Inflammatory Bowel Disease Drugs

2 Manufacturing Cost Structure Analysis of Inflammatory Bowel Disease Drugs
2.1 Raw Material Suppliers and Price Analysis of Inflammatory Bowel Disease Drugs
2.2 Equipment Suppliers and Price Analysis of Inflammatory Bowel Disease Drugs
2.3 Labor Cost Analysis of Inflammatory Bowel Disease Drugs
2.4 Other Costs Analysis of Inflammatory Bowel Disease Drugs
2.5 Manufacturing Cost Structure Analysis of Inflammatory Bowel Disease Drugs
2.6 Manufacturing Process Analysis of Inflammatory Bowel Disease Drugs

3 Technical Data and Manufacturing Plants Analysis of Inflammatory Bowel Disease Drugs
3.1 Capacity and Commercial Production Date of Global Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Inflammatory Bowel Disease Drugs Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Inflammatory Bowel Disease Drugs Major Manufacturers in 2015

4 Global Inflammatory Bowel Disease Drugs Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Inflammatory Bowel Disease Drugs Capacity and Growth Rate Analysis
4.2.2 2015 Inflammatory Bowel Disease Drugs Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Inflammatory Bowel Disease Drugs Sales and Growth Rate Analysis
4.3.2 2015 Inflammatory Bowel Disease Drugs Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Inflammatory Bowel Disease Drugs Sales Price
4.4.2 2015 Inflammatory Bowel Disease Drugs Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Inflammatory Bowel Disease Drugs Gross Margin
4.5.2 2015 Inflammatory Bowel Disease Drugs Gross Margin Analysis (Company Segment)

5 Inflammatory Bowel Disease Drugs Regional Market Analysis
5.1 USA Inflammatory Bowel Disease Drugs Market Analysis
5.1.1 USA Inflammatory Bowel Disease Drugs Market Overview
5.1.2 USA 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.1.4 USA 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
5.2 China Inflammatory Bowel Disease Drugs Market Analysis
5.2.1 China Inflammatory Bowel Disease Drugs Market Overview
5.2.2 China 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.2.4 China 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
5.3 Europe Inflammatory Bowel Disease Drugs Market Analysis
5.3.1 Europe Inflammatory Bowel Disease Drugs Market Overview
5.3.2 Europe 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.3.4 Europe 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
5.4 South America Inflammatory Bowel Disease Drugs Market Analysis
5.4.1 South America Inflammatory Bowel Disease Drugs Market Overview
5.4.2 South America 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.4.3 South America 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.4.4 South America 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
5.5 Japan Inflammatory Bowel Disease Drugs Market Analysis
5.5.1 Japan Inflammatory Bowel Disease Drugs Market Overview
5.5.2 Japan 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.5.4 Japan 2015 Inflammatory Bowel Disease Drugs Market Share Analysis
5.6 Africa Inflammatory Bowel Disease Drugs Market Analysis
5.6.1 Africa Inflammatory Bowel Disease Drugs Market Overview
5.6.2 Africa 2011-2016E Inflammatory Bowel Disease Drugs Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Africa 2011-2016E Inflammatory Bowel Disease Drugs Sales Price Analysis
5.6.4 Africa 2015 Inflammatory Bowel Disease Drugs Market Share Analysis

6 Global 2011-2016E Inflammatory Bowel Disease Drugs Segment Market Analysis (by Type)
6.1 Global 2011-2016E Inflammatory Bowel Disease Drugs Sales by Type
6.2 Different Types Inflammatory Bowel Disease Drugs Product Interview Price Analysis
6.3 Different Types Inflammatory Bowel Disease Drugs Product Driving Factors Analysis

7 Global 2011-2016E Inflammatory Bowel Disease Drugs Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis

8 Major Manufacturers Analysis of Inflammatory Bowel Disease Drugs
8.1 Merck & Company
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Merck & Company 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Merck & Company 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.2 Janssen Pharmaceuticals
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Janssen Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Janssen Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.3 Abbvie
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Abbvie 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Abbvie 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.4 Biogen Idec
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Biogen Idec 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Biogen Idec 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.5 UCB
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 UCB 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 UCB 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.6 Shire
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Shire 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Shire 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.7 Pfizer
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Pfizer 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Pfizer 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.8 Novartis
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Novartis 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Novartis 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.9 Novo Nordisk
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Novo Nordisk 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Novo Nordisk 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.10 Boehringer Ingelheim
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Boehringer Ingelheim 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Boehringer Ingelheim 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.11 Salix Pharmaceuticals
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Salix Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Salix Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.12 Genentech
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Genentech 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Genentech 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.13 Amgen
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Amgen 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Amgen 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.14 Mitsubishi Tanabe
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Mitsubishi Tanabe 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Mitsubishi Tanabe 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.15 Akebia Therapeutics
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Akebia Therapeutics 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Akebia Therapeutics 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.16 Celltrion
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Celltrion 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Celltrion 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.17 ChemoCentryx
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 ChemoCentryx 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 ChemoCentryx 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis
8.18 Ferring Pharmaceuticals
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Ferring Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Ferring Pharmaceuticals 2015 Inflammatory Bowel Disease Drugs Business Region Distribution Analysis

9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.2.2 China 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.2.3 Europe 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.2.4 South America 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.2.5 Japan 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.2.6 Africa 2016-2021 Inflammatory Bowel Disease Drugs Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 Inflammatory Bowel Disease Drugs Marketing Model Analysis
10.1 Inflammatory Bowel Disease Drugs Regional Marketing Model Analysis
10.2 Inflammatory Bowel Disease Drugs International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Inflammatory Bowel Disease Drugs by Regions
10.4 Inflammatory Bowel Disease Drugs Supply Chain Analysis

11 Consumers Analysis of Inflammatory Bowel Disease Drugs
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 New Project Investment Feasibility Analysis of Inflammatory Bowel Disease Drugs
12.1 New Project SWOT Analysis of Inflammatory Bowel Disease Drugs
12.2 New Project Investment Feasibility Analysis of Inflammatory Bowel Disease Drugs

13 Conclusion of the Global Inflammatory Bowel Disease Drugs Market Professional Survey Report 2016

Enquiry About Report

Need More Information

SIMILAR MARKET STUDIES

Global Onychomycosis (Tinea Unguium) Drug Detailed Analysis Report 2017-2022

This report splits Onychomycosis (Tinea Unguium) Drug by Product Drug Form, by Product Usage Type. This shares the history data information from 2012 to 2016, and forecast from 2017 to 2022. And this report mainly introduces volume and value market share by players, by regions, by product type, by consumers and ...

July 2017 | $3250 | View Details >>

2017-2022 Botulinum Toxins Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

This report studies the Botulinum Toxins market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Botulinum Toxins market by product type and applications/end industries. The global ...

July 2017 | $2960 | View Details >>

Global Phyto Squalane Market Research Report 2017

In this report, the global Phyto Squalane market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, ...

July 2017 | $2900 | View Details >>

Global Shark Squalane Market Research Report 2017

In this report, the global Shark Squalane market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, ...

July 2017 | $2900 | View Details >>

UPCOMING MARKET RESEARCH REPORTS

Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017 | Price:$ 5370 | Pre Book Price:$ 5370

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

March 2017 | Price:$ 7695 | Pre Book Price:$ 7695

Radiopharmaceuticals Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Radiopharmaceutical is a radioactive pharmaceutical agent which is used diagnostic or therapeutic procedures. A radiopharmaceutical is made up of two components that are drug component and radioactive component. This radioactive ...

March 2017 | Price:$ 7695 | Pre Book Price:$ 7695

Pharmaceutical Excipients Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Pharmaceutical excipients are substances other than the pharmacologically active drug or prodrug which are included in the manufacturing process or are contained in a finished pharmaceutical product dosage form. The ...

March 2017 | Price:$ 7695 | Pre Book Price:$ 7695

Over the Counter (OTC) & Diet Supplementary Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of ...

March 2017 | Price:$ 7695 | Pre Book Price:$ 7695

World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017 | Price:$ 5370 | Pre Book Price:$ 5370